In addition, STAT1, a classical transcription factor that participates in the JAK/STAT pathway or cascades with the RIG1, NF-kappaB, and IRF signaling pathways, has been reported to mediate tumor immunity in multiple myeloma. Here, TRIM63 is linked to plasma cell myeloma.